S100A8 and systemic lupus erythematosus: There is growing experimental and clinical evidence that serum S100A8 levels are higher in patients with SLE than in healthy controls (HCs) and are associated with disease activity, glomerulonephritis, and anti-double-stranded DNA (dsDNA) antibodies (Ab) (11–13).